Atlas Trials

Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.

Clinical trial NCT05282082 · COMPLETED

Trial details

NCT number
NCT05282082
Sponsor
Erasmus Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
Pseudomonas AeruginosaColonization, AsymptomaticNosocomial Infection
Start date
2022-03-01
Primary completion
2024-06-30
Enrollment
2105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.